Literature DB >> 21417758

Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.

Bruna Coelho Carvalho1, Ludimila Paula Vaz Cardoso, Sirlene Damasceno, Mariane Martins de Araújo Stefani.   

Abstract

The diverse Brazilian AIDS epidemic has reached small cities and scant molecular information is available about the epidemic in Northern Brazil, where the incidence is growing. This study describes transmitted drug resistance and subtypes in the protease (PR) and reverse transcriptase (RT) regions among naive patients recruited in Palmas, the capital of Tocantins State, a newly built city in Northern Brazil. PR/RT regions were retrotranscribed from plasma HIV-1 RNA and 52 were sequenced after direct nested PCR. HIV-1 subtypes were assigned by phylogenetic analysis. Transmitted drug resistance was analyzed by the Calibrated Population Resistance tool Stanford Surveillance Drug Resistance Mutation. Most patients included (59.6%) were males, the median age was 30 years and were mainly referred because of heterosexual or homosexual unprotected sex. One male patient was from the Karajás indigenous tribe. The prevalence of transmitted resistance was 11.5% (CI 95%, 4.4-23.4%): nonnucleoside RT inhibitor mutations (n=3), nucleoside RT inhibitor mutations (n=2), and protease inhibitor mutations (n=1). Dual or triple class resistance was not observed. HIV-1 subtype B(PR)/B(RT) represented 78.8%, 5.8% were subtype C(PR)/C(RT), and 1.9% were subtype F1(PR)/F1(RT). Recombinant viruses represented 13.5% (07/52): B(PR)/F1(RT) (n=1), B(PR)/BF1(RT) (n=4), and C(PR)/CF1(RT) (n=2). This study about the AIDS epidemic in the recently founded city of Palmas/Tocantins in inland Northern Brazil shows moderate levels of transmitted drug resistance and the circulation of diverse recombinant viruses. This pattern is similar to what has been described in major metropolitan cities, suggesting the influence of imported cases from the south/southeast. Moreover these results indicate that patients from this setting should be monitored regarding transmitted drug resistance mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417758     DOI: 10.1089/AID.2010.0334

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

Review 1.  Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Authors:  Kathryn M Stadeli; Douglas D Richman
Journal:  Antivir Ther       Date:  2012-10-10

2.  Contribution of Epidemiological Predictors in Unraveling the Phylogeographic History of HIV-1 Subtype C in Brazil.

Authors:  Tiago Gräf; Bram Vrancken; Dennis Maletich Junqueira; Rúbia Marília de Medeiros; Marc A Suchard; Philippe Lemey; Sabrina Esteves de Matos Almeida; Aguinaldo Roberto Pinto
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

3.  HIV type 1 molecular epidemiology in pol and gp41 genes among naive patients from Mato Grosso do Sul State, central western Brazil.

Authors:  Alexsander Augusto da Silveira; Ludimila Paula Vaz Cardoso; Roberta Barbosa Lopes Francisco; Mariane Martins de Araújo Stefani
Journal:  AIDS Res Hum Retroviruses       Date:  2011-07-26       Impact factor: 2.205

4.  Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.

Authors:  Rosana Alcalde; Monick L Guimarães; Alberto J S Duarte; Jorge Casseb
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

5.  Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.

Authors:  Ratish Gambhira; Brandon F Keele; John B Schell; Meredith J Hunter; Jason P Dufour; David C Montefiori; Haili Tang; John K Rose; Nina Rose; Preston A Marx
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 6.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

7.  Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil.

Authors:  Joao Leandro Paula Ferreira; Rosangela Rodrigues; Andre Minhoto Lança; Valeria Correia de Almeida; Simone Queiroz Rocha; Taisa Grotta Ragazzo; Denise Lotufo Estevam; Luis Fernando de Macedo Brigido
Journal:  Adv Virol       Date:  2013-01-15

8.  Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil.

Authors:  Edson Delatorre; José C Couto-Fernandez; Monick Lindenmayer Guimarães; Ludimila Paula Vaz Cardoso; Keila Correia de Alcantara; Mariane Martins de Araújo Stefani; Hector Romero; Caio C M Freire; Atila Iamarino; Paolo M de A Zanotto; Mariza G Morgado; Gonzalo Bello
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

9.  Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots.

Authors:  Celina M P de Moraes Soares; Tania R C Vergara; Carlos Brites; Jose D U Brito; Gorki Grinberg; Marcos M Caseiro; Carlos Correa; Theodoro A Suffert; Flavio R Pereira; Michelle Camargo; Luiz M Janini; Shirley Komninakis; Maria C A Sucupira; Ricardo S Diaz
Journal:  J Int AIDS Soc       Date:  2014-09-22       Impact factor: 5.396

10.  The Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil.

Authors:  Carmen Andréa F Lopes; Marcelo A Soares; Diego R Falci; Eduardo Sprinz
Journal:  Biomed Res Int       Date:  2015-10-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.